netFormulary Northern Lincolnshire NHS
Formulary  
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
Notes:

NHS England - The Cancer Drugs Fund

 

Please refer to the North East Yorkshire and Humber Clinical Alliance for full cancer guidelines and chemotherapy regimens.

North East Yorkshire and Humber Clinical Alliance

 Details...
08.01.02  Expand sub section  Anthracyclines and other cytotoxic antibiotics
Cytotoxic Drug Bleomycin
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

injection

 
   
Cytotoxic Drug Dactinomycin (Cosmegen Lyovac®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

injection

 
   
Daunorubicin (DaunoXome®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

injection

 
   
Cytotoxic Drug Daunorubicin 44mg and Cytarabine 100mg (Vyxeos®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Injection

 
Link  NICE TA552:Liposomal cytarabine–daunorubicin for untreated acute myeloid leukaemia
   
Cytotoxic Drug Doxorubicin
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Injection

 
   
Cytotoxic Drug Doxorubicin (Caelyx®)
(Liposomal)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
BlueTeq

Concentrate for intravenous infusion

 
Link  NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
Link  NICE TA440 : Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine
   
Cytotoxic Drug Epirubicin
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Injection

 
   
Cytotoxic Drug Idarubicin (Zavedos®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Capsule, injection

 
   
Cytotoxic Drug Mitomycin
(injection, bladder)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Injection, bladder instillation

 
   
Mitoxantrone (Onkotrone®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Infusion

 
   
Cytotoxic Drug Mitoxantrone (Mitozantrone)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Infusion

 
   
Cytotoxic Drug Pixantrone
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
 
Link  NICE TA306: Pixantrone monotherapy
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Green -Medicines suitable for routine use within primary care and Secondary care Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies  

Amber

Amber- Medicines suitable to be prescribed in primary care after specialist /Consultant recommendation or initiation. A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust Medicines and Therapeutic Committee and approved by the Area Prescribing Committee.   

Red

Red-Hospital initiation and continuation only  

Amber Shared Care Protocol

AMBER SHARE CARE PROTOCOL- Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised  

Blue

To be supplied from the appropriate commissioned provider.   

Green 2

GREEN 2- to be prescribed by primary care only   

Grey

GREY- NON FORMULARY (As agreed by Area Prescribing Committee)  

netFormulary